XML 18 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Consolidated Entity Excluding Consolidated Funds
Additional paid-in capital
Consolidated Entity Excluding Consolidated Funds
Retained earnings (deficit)
Consolidated Entity Excluding Consolidated Funds
Accumulated other comprehensive income (loss)
Consolidated Entity Excluding Consolidated Funds
Total stockholders’ equity
Consolidated Entity Excluding Consolidated Funds
Non- controlling interests
Consolidated Entity Excluding Consolidated Funds
Non- controlling interests
Consolidated Funds
Beginning balance (in shares) at Dec. 31, 2020   79.4            
Beginning balance at Dec. 31, 2020 $ 384.4 $ 0.1 $ 492.4 $ (176.5) $ (13.6) $ 302.4 $ 1.7 $ 80.3
Increase (Decrease) in Stockholders' Equity                
Capital contributions 3.8           3.8  
Equity-based compensation 0.4   0.4     0.4    
Foreign currency translation adjustment 1.1       1.1 1.1    
Amortization related to derivatives securities, net of tax 0.6       0.6 0.6    
Other changes in non-controlling interests 0.1           0.1  
Dividends (0.8)     (0.8)   (0.8)    
Net income 40.4     27.0   27.0   13.4
Ending balance (in shares) at Mar. 31, 2021   79.4            
Ending balance at Mar. 31, 2021 430.0 $ 0.1 492.8 (150.3) (11.9) 330.7 5.6 93.7
Beginning balance at Dec. 31, 2020 384.4              
Increase (Decrease) in total equity and redeemable non-controlling interest in consolidated Funds                
Capital contributions 3.8              
Equity-based compensation 0.4              
Foreign currency translation adjustment 1.1              
Amortization related to derivative securities, net of tax 0.6              
Other changes in non-controlling interests 0.1           0.1  
Dividends (0.8)              
Net income 40.4              
Ending balance at Mar. 31, 2021 430.0              
Beginning balance (in shares) at Dec. 31, 2021   45.4            
Beginning balance at Dec. 31, 2021 (17.6) $ 0.0 0.0 (6.8) (10.8) (17.6) 0.0 0.0
Increase (Decrease) in Stockholders' Equity                
Issuance of common stock (in shares)   0.2            
Issuance of common stock 0.0              
Repurchase of common stock (in shares)   (4.2)            
Repurchase of common stock (103.2)     (103.2)   (103.2)    
Equity-based compensation 0.9   0.9     0.9    
Foreign currency translation adjustment (0.7)       (0.7) (0.7)    
Amortization related to derivatives securities, net of tax 1.6       1.6 1.6    
Withholding tax related to stock option exercise (2.3)   (0.9) (1.4)   (2.3)    
Dividends (0.4)     (0.4)   (0.4)    
Net income 23.8     23.8   23.8    
Ending balance (in shares) at Mar. 31, 2022   41.4            
Ending balance at Mar. 31, 2022 (97.9) $ 0.0 $ 0.0 $ (88.0) $ (9.9) $ (97.9) $ 0.0 $ 0.0
Beginning balance at Dec. 31, 2021 (17.6)              
Increase (Decrease) in total equity and redeemable non-controlling interest in consolidated Funds                
Repurchase of common stock (103.2)              
Equity-based compensation 0.9              
Foreign currency translation adjustment (0.7)              
Amortization related to derivative securities, net of tax 1.6              
Dividends (0.4)              
Net income 23.8              
Ending balance at Mar. 31, 2022 $ (97.9)